Structure Elucidation, Total Synthesis, Antibacterial In Vivo Efficacy and Biosynthesis Proposal of Myxobacterial Corramycin**-Reference-Cited by-同舟云学术

Structure Elucidation, Total Synthesis, Antibacterial In Vivo Efficacy and Biosynthesis Proposal of Myxobacterial Corramycin**

Published:2022-11-21 Issue:51 Volume:61 Page:
ISSN:1433-7851
Container-title:Angewandte Chemie International Edition
language:en
Short-container-title:Angew Chem Int Ed

Author:

Couturier Cédric¹,Groß Sebastian²,von Tesmar Alexander²,Hoffmann Judith²,Deckarm Selina²,Fievet Anouchka³,Dubarry Nelly³,Taillier Thomas¹,Pöverlein Christoph⁴,Stump Heike⁴,Kurz Michael⁴,Toti Luigi⁴,Haag Richter Sabine⁴,Schummer Dietmar⁵,Sizun Philippe⁴,Hoffmann Michael²,Prasad Awal Ram²,Zaburannyi Nestor²,Harmrolfs Kirsten²,Wink Joachim⁶,Lessoud Emilie¹,Vermat Thierry¹,Cazals Veronique¹,Silve Sandra¹,Bauer Armin⁴,Mourez Michael⁷,Fraisse Laurent⁸,Leroi‐Geissler Corinne¹,Rey Astrid⁹,Versluys Stéphanie¹⁰,Bacqué Eric¹,Müller Rolf²^ORCID,Renard Stephane³

Affiliation:

1. Evotec 1541, avenue Marcel Mérieux 69280 Marcy L'Etoile France

2. Microbial Natural Products Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) Helmholtz Centre for Infection Research (HZI) and Department of Pharmacy at Saarland University Campus Building E8.1 66123 Saarbrücken Germany

3. Evotec 40 avenue Tony Garnier 69007 Lyon France

4. Sanofi 13, Quai Jules Guesde 94400 Vitry-sur-Seine France

5. Technische Hochschule Mittelhessen Wiesenstraße 14 35390 Gießen Germany

6. Mikrobielle Stammsammlung Helmholtz Centre for Infection Research (HZI) Inhoffenstraße 7 38124 Braunschweig Germany

7. Ecole d'Ingénieurs de Purpan 75 voie du Toec BP57611, 31076 Toulouse France

8. Drug for Neglected Diseases Initiative Chemin Camille-Vidart 15 1202 Geneva Switzerland

9. Charles River Laboratories 327 impasse du domaine rozier 69210 Saint-Germain-Nuelles France

10. Evotec 195, route d'Espagne 31000 Toulouse France

Publisher

Wiley

Subject

General Chemistry,Catalysis

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/anie.202210747

Reference54 articles.

1. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis

2. World Health Orgaization (WHO) “Global Antimicrobial Resistance Surveillance System (GLASS) Report. Early implementation” can be found underhttp://apps.who.int/iris/bitstream/handle/10665/259744/9789241513449-eng.pdf;jsessionid=97E045EBFE3B29F286CBA3EE8360F0D1?sequence=1 2018.

3. Resistance fighters

4. Antibacterial Activity of Eravacycline (TP-434), a Novel Fluorocycline, against Hospital and Community Pathogens

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Corallococcus senghenyddensis sp. nov., a myxobacterium with potent antimicrobial activity;Journal of Applied Microbiology;2024-04-22

2. Chemical Ligation-Mediated Total Synthesis of Corramycin;Organic Letters;2024-04-02

3. The Peptide Antibiotic Corramycin Adopts a β-Hairpin-like Structure and Is Inactivated by the Kinase ComG;Journal of the American Chemical Society;2024-03-21

4. Recent advances in discovery and biosynthesis of natural products from myxobacteria: an overview from 2017 to 2023;Natural Product Reports;2024

5. Optimization of the Antibacterial Spectrum and the Developability Profile of the Novel-Class Natural Product Corramycin;Journal of Medicinal Chemistry;2023-12-13